South Asian Journal of Cancer

LETTER TO THE EDITOR
Year
: 2020  |  Volume : 9  |  Issue : 1  |  Page : 6--12

An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome


Vikas T Talreja, Vanita Noronha, Amit Joshi, Vijay Patil, Kumar Prabhash 
 Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Dr. Vanita Noronha
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
India




How to cite this article:
Talreja VT, Noronha V, Joshi A, Patil V, Prabhash K. An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome.South Asian J Cancer 2020;9:6-12


How to cite this URL:
Talreja VT, Noronha V, Joshi A, Patil V, Prabhash K. An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome. South Asian J Cancer [serial online] 2020 [cited 2020 Aug 9 ];9:6-12
Available from: http://journal.sajc.org/article.asp?issn=2278-330X;year=2020;volume=9;issue=1;spage=6;epage=12;aulast=Talreja;type=0